139 related articles for article (PubMed ID: 31502250)
41. Multifocal nerve lesions and LZTR1 germline mutations in segmental schwannomatosis.
Farschtschi S; Mautner VF; Pham M; Nguyen R; Kehrer-Sawatzki H; Hutter S; Friedrich RE; Schulz A; Morrison H; Jones DT; Bendszus M; Bäumer P
Ann Neurol; 2016 Oct; 80(4):625-8. PubMed ID: 27472264
[TBL] [Abstract][Full Text] [Related]
42. Molecular Analysis of Hybrid Neurofibroma/Schwannoma Identifies Common Monosomy 22 and α-T-Catenin/CTNNA3 as a Novel Candidate Tumor Suppressor.
Stahn V; Nagel I; Fischer-Huchzermeyer S; Oyen F; Schneppenheim R; Gesk S; Bohring A; Chikobava L; Young P; Gess B; Werner M; Senner V; Harder A
Am J Pathol; 2016 Dec; 186(12):3285-3296. PubMed ID: 27765635
[TBL] [Abstract][Full Text] [Related]
43. DGCR8 and the six hit, three-step model of schwannomatosis.
Nogué C; Chong AS; Grau E; Han H; Dorca E; Roca C; Mosquera JL; Lázaro C; Foulkes WD; Brunet J; Rivera B
Acta Neuropathol; 2022 Jan; 143(1):115-117. PubMed ID: 34821987
[No Abstract] [Full Text] [Related]
44. Comparison of the frequency of loss-of-function LZTR1 variants between schwannomatosis patients and the general population.
Deng F; Evans DG; Smith MJ
Hum Mutat; 2022 Jul; 43(7):919-927. PubMed ID: 35391499
[TBL] [Abstract][Full Text] [Related]
45. Schwannomatosis: a new member of neurofibromatosis family.
Chen SL; Liu C; Liu B; Yi CJ; Wang ZX; Rong YB; Zhu J; Ding Y; Tian GL
Chin Med J (Engl); 2013 Jul; 126(14):2656-60. PubMed ID: 23876891
[TBL] [Abstract][Full Text] [Related]
46. The Secretomes of Painful Versus Nonpainful Human Schwannomatosis Tumor Cells Differentially Influence Sensory Neuron Gene Expression and Sensitivity.
Ostrow KL; Donaldson KJ; Caterina MJ; Belzberg A; Hoke A
Sci Rep; 2019 Sep; 9(1):13098. PubMed ID: 31511601
[TBL] [Abstract][Full Text] [Related]
47. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.
Caltabiano R; Magro G; Polizzi A; Praticò AD; Ortensi A; D'Orazi V; Panunzi A; Milone P; Maiolino L; Nicita F; Capone GL; Sestini R; Paganini I; Muglia M; Cavallaro S; Lanzafame S; Papi L; Ruggieri M
Childs Nerv Syst; 2017 Jun; 33(6):933-940. PubMed ID: 28365909
[TBL] [Abstract][Full Text] [Related]
48. Response to Trevisson et al.
Zhang K; Lin JW; Chiu WT; Yen Y
Genet Med; 2015 Apr; 17(4):313-4. PubMed ID: 25835194
[No Abstract] [Full Text] [Related]
49. Double somatic SMARCB1 and NF2 mutations in sporadic spinal schwannoma.
Paganini I; Capone GL; Vitte J; Sestini R; Putignano AL; Giovannini M; Papi L
J Neurooncol; 2018 Mar; 137(1):33-38. PubMed ID: 29230670
[TBL] [Abstract][Full Text] [Related]
50. Creation of an international registry to support discovery in schwannomatosis.
Ostrow KL; Bergner AL; Blakeley J; Evans DG; Ferner R; Friedman JM; Harris GJ; Jordan JT; Korf B; Langmead S; Leschziner G; Mautner V; Merker VL; Papi L; Plotkin SR; Slopis JM; Smith MJ; Stemmer-Rachamimov A; Yohay K; Belzberg AJ
Am J Med Genet A; 2017 Feb; 173(2):407-413. PubMed ID: 27759912
[TBL] [Abstract][Full Text] [Related]
51. Rhabdoid tumor predisposition syndrome.
Sredni ST; Tomita T
Pediatr Dev Pathol; 2015; 18(1):49-58. PubMed ID: 25494491
[TBL] [Abstract][Full Text] [Related]
52. Updated protocol for genetic testing, screening and clinical management of individuals at risk of NF2-related schwannomatosis.
Halliday D; Emmanouil B; Evans DGR
Clin Genet; 2023 May; 103(5):540-552. PubMed ID: 36762955
[TBL] [Abstract][Full Text] [Related]
53. WP1066 induces cell death in a schwannomatosis patient-derived schwannoma cell line.
Allaf A; Victoria B; Rosario R; Misztal C; Humayun Gultekin S; Dinh CT; Fernandez-Valle C
Cold Spring Harb Mol Case Stud; 2022 Jun; 8(4):. PubMed ID: 35732500
[TBL] [Abstract][Full Text] [Related]
54. SMARCA4-associated schwannomatosis.
Chan-Pak-Choon F; Roca C; Chong AS; Nogué C; Dahlum S; Austin R; Mar Fan H; van Spaendonck-Zwarts KY; Lambie NK; Robertson T; Siebert R; Rivera B; Foulkes WD
Acta Neuropathol; 2023 Apr; 145(4):505-507. PubMed ID: 36786840
[No Abstract] [Full Text] [Related]
55. What to know about schwannomatosis: a literature review.
Schraepen C; Donkersloot P; Duyvendak W; Plazier M; Put E; Roosen G; Vanvolsem S; Wissels M; Bamps S
Br J Neurosurg; 2022 Apr; 36(2):171-174. PubMed ID: 33263426
[TBL] [Abstract][Full Text] [Related]
56. Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.
Mansouri S; Suppiah S; Mamatjan Y; Paganini I; Liu JC; Karimi S; Patil V; Nassiri F; Singh O; Sundaravadanam Y; Rath P; Sestini R; Gensini F; Agnihotri S; Blakeley J; Ostrow K; Largaespada D; Plotkin SR; Stemmer-Rachamimov A; Ferrer MM; Pugh TJ; Aldape KD; Papi L; Zadeh G
Acta Neuropathol; 2021 Jan; 141(1):101-116. PubMed ID: 33025139
[TBL] [Abstract][Full Text] [Related]
57. Unilateral vestibular schwannoma in a patient with schwannomatosis in the absence of LZTR1 mutation.
Mehta GU; Feldman MJ; Wang H; Ding D; Chittiboina P
J Neurosurg; 2016 Dec; 125(6):1469-1471. PubMed ID: 26848914
[TBL] [Abstract][Full Text] [Related]
58. [Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis: an evolving paradigm].
Dereure O
Ann Dermatol Venereol; 2009 Mar; 136(3):296-7. PubMed ID: 19328320
[No Abstract] [Full Text] [Related]
59. Neurofibromas in LZTR1 schwannomatosis.
Groen JL; Moghadasi S; Spruijt L; Korpershoek E; van Ierland Y; van Wezel JT; van Duinen S; Malessy MJA; Lesnik Oberstein SAJ
Clin Genet; 2022 May; 101(5-6):571-572. PubMed ID: 35178712
[No Abstract] [Full Text] [Related]
60. Schwannomatosis: the overlooked neurofibromatosis?
Koontz NA; Wiens AL; Agarwal A; Hingtgen CM; Emerson RE; Mosier KM
AJR Am J Roentgenol; 2013 Jun; 200(6):W646-53. PubMed ID: 23701098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
